Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

The Department of Agriculture (DA) hopes to secure the approval of the Food and Drug Administration (FDA) by next month for ...

WASHINGTON — The Environmental Protection Agency has issued new guidance directing that spending items greater than $50,000 now require approval from Elon Musk’s Department of Government ...

“So that we don’t learn five years after Vioxx was approved that 38,000 Americans died from it,” he said. Open questions: But the Johns Hopkins surgeon also said the FDA could potentially ...

scPharmaceuticals (SCPH) announced that the FDA has approved the supplemental new drug application for Furoscix to expand the indication to include treatment of edema in patients with chronic ...

Venus Remedies announced on Tuesday that it has received marketing authorization from the Philippines for a medication used to ... agent (SRBA), is Venus Remedies' first global marketing approval. The ...

The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled bleeding or in those who require urgent surgery or invasive procedure.

It noted at the time more countries would get access as regulators approved the feature, and the FDA was apparently the first to come through outside of Europe, boosting support to 15 countries.

Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

The OFA additionally argued that even producers of FDA-approved semaglutide revealed in a recent SEC filing that the “supply constraints’ and ‘drug shortage notifications’ will continue into the ...